GoodRx teams with Boehringer on Humira biosimilar

GoodRx teams with Boehringer on Humira biosimilar

Source: 
Axios
snippet: 

A new partnership between prescription savings platform GoodRx and drugmaker Boehringer Ingelheim will make the company's Humira knockoff available for a discounted cash pay price of $550.